Emerging infectious diseases are those whose incidence in humans has increased in the past 2 decades or threaten to increase in the near future. These diseases, which respect no national boundaries, can challenge efforts to protect workers as prevention and control recommendations may not be immediately available. The occupational safety and health community can prepare for these unpredictable disease outbreaks and prevent disease transmission with these resources for protecting workers, particularly healthcare workers, nurses, doctors, and first responders.
Your thyroid produces thyroid hormone, which controls many activities in your body, including how fast you burn calories and how fast your heart beats. Diseases of the thyroid cause it to make either too much or too little of the hormone. Depending on how much or how little hormone your thyroid makes, you may often feel restless or tired, or you may lose or gain weight. Women are more likely than men to have thyroid diseases, especially right after pregnancy and after menopause.
The three diseases you mention are 3 distinct entities.
CML or chronic myelogenous leukemia is a disease in which patients have too many mature white blood cells. It is considered a myeloproliferative disorder-a condition in which the bone marrow makes too many cells. This disease is diagnosed by the presence of either the Philadelphia Chromosome or the gene made by the Philadelphia chromosome, called bcr-abl. New treatments, which target this abnormal gene, have been developed. It is considered in the list of possible diagnoses, this chromosome is looked for so that appropriate therapy is not missed.
AML or acute myelogenous leukemia is a disease in which patients have too many immature white blood cells in their bone marrow that are not capable of maturing properly. These immature cells act very rapidly and can cause life-threatening problems if the disease is not treated promptly.
CMMoL or chronic myelomonocytic leukemia is a disorder of the bone marrow where the bone marrow is making too many white blood cells called monocytes. The bone marrow appears myeloproliferative but the cells that it makes are not normal mature cells and do not function properly. This disorder is called a myelodysplatic disorder (funny looking bone marrow). Its progression and outcome is variable and can be predicted to some degree by the blood counts and bone marrow findings.
By Hannah Lathen
SE student Janna Gentry lives with a mother who has Crohn’s disease and lupus, causing her to have stomach ulcers and inflamed joints.
Online student Laken Reeder has Sjogren’s syndrome, causing extreme pain and difficulties with eating.
TCC students are fighting hidden and misunderstood battles with autoimmune diseases. Even though they affect 1 in 6 people, many do not understand what they are or that they exist.
An autoimmune disease occurs in the body when one’s immune system starts attacking healthy cells. Instead of protecting the body from foreign invaders, the system starts hurting organs.
About 79 million Americans currently have HPV. Many people with HPV are unaware that they are infected. And each year, more than 11,000 women in the United States get cervical cancer.
Most deaths from cervical cancer could be prevented by regular screenings and follow-up care. Cervical cancer screenings can help detect abnormal (changed) cells early, before they turn into cancer.
Take the time to learn more about HPV (human papillomavirus) and cervical cancer.
Here are several helpful links to learn more about HPV and cervical cancer prevention.
Cervical Cancer: What to Know.
HPV Vaccination & Cancer Prevention
Keep up with Plasma MedResearch through our facebook page.
(SOURCES: 1, 2 )
Article Source: http://www.medscape.com/viewarticle/878764
There was a time when women diagnosed with lupus were cautioned against getting pregnant; the combination of lupus and pregnancy was thought to be too dangerous for mother and child. However, research by Jane Salmon, MD, a rheumatologist at the Hospital for Special Surgery (HSS) in New York City, is now helping change this belief. By carefully risk-stratifying patients on the basis of clinical and biological markers, it seems that the vast majority of pregnant patients with lupus can be assured that their pregnancies will be uncomplicated. Medscape recently spoke to Dr Salmon about her work.
Medscape: Tell us a little about how you began studying pregnancy and lupus.
Dr Salmon: Patients with lupus tend to be young women in their reproductive years. Lupus generally presents between age 20 and 40 years, and 90% of the patients are women. Some of the first questions they often ask when they receive their diagnosis are, “Can I have children?” “Will my pregnancy be safe?” and “Will my children have lupus?”
In the 1980s, when I was training in rheumatology, the feeling was that pregnancy in lupus was dangerous. This wasn’t based on strong evidence, but on the rational concept that because lupus tends to be a disease of women, hormones may play a role in disease pathogenesis, and pregnancy is a state with high levels of female hormones (ie, estrogens, progesterone). Thus, it was anticipated that patients with lupus who become pregnant would have severe flares. And in fact, patients who become pregnant when their disease is active and not well-controlled often develop even more severe organ dysfunction. So there was clinical basis for the anxiety among the physicians, but perhaps it was applied too broadly.
Medscape: How has your research helped changed this way of thinking?
Dr Salmon: Patients asked for and deserve data around such an important question. They wanted the evidence that, in fact, this was true. And we wanted to identify the predictors of poor pregnancy outcomes and the mechanisms that caused damage to the placenta and the developing baby.